VOR
Vor Biopharma Inc.
Latest Form 4:Sale$4KbyRA CAPITAL MANAGEMENT, L.P. (10% Owner) · filed Jul 21, 2026
Vor Biopharma Inc. (VOR) has 9 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 21, 2026.
The most active filer is 10% Owner RA CAPITAL MANAGEMENT, L.P. with 15 filings. Insiders have net sold $49.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jean-Paul Kress
- Employees:76
- HQ:Boston, MA, US
- IPO:2021-02-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59.8M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Sale | 213 | $4K | Jul 21 | SEC ↗ | |
| Director, 10% Owner | Sale | 165,150 | $2.6M | Apr 24 | SEC ↗ | |
| Director, 10% Owner | Sale | 458,411 | $7.5M | Apr 21 | SEC ↗ | |
| Director, 10% Owner | Sale | 171,963 | $2.7M | Apr 21 | SEC ↗ | |
| Director, 10% Owner | Sale | 530,610 | $8.6M | Apr 15 | SEC ↗ | |
| Director, 10% Owner | Sale | 153,735 | $2.5M | Apr 15 | SEC ↗ | |
| Director, 10% Owner | Sale | 53,644 | $859K | Apr 15 | SEC ↗ | |
| Director, 10% Owner | Sale | 484,104 | $8.0M | Apr 10 | SEC ↗ | |
| Director, 10% Owner | Sale | 135,201 | $2.2M | Apr 10 | SEC ↗ | |
| Director, 10% Owner | Sale | 828 | $13K | Apr 10 | SEC ↗ | |
| Director, 10% Owner | Sale | 260,000 | $4.7M | Apr 6 | SEC ↗ | |
| Director, 10% Owner | Sale | 589,257 | $9.8M | Apr 6 | SEC ↗ | |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 124,311 | $3.4M | Oct 30 | SEC ↗ |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 251,518 | $6.3M | Oct 30 | SEC ↗ |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 24,579 | $617K | Oct 30 | SEC ↗ |
Related companies
Vor Biopharma Inc. is in the Healthcare sector.